Evidence of neurodegeneration in autism spectrum disorder
- PMID: 23925007
- PMCID: PMC3751488
- DOI: 10.1186/2047-9158-2-17
Evidence of neurodegeneration in autism spectrum disorder
Abstract
Autism spectrum disorder (ASD) is a neurological disorder in which a significant number of children experience a developmental regression characterized by a loss of previously-acquired skills and abilities. Loss of neurological function in ASD, as observed in affected children who have regressed, can be explained as neurodegeneration. Although there is research evidence of neurodegeneration or progressive encephalopathy in ASD, the issue of neurodegeneration in ASD is still under debate. Evidence of neurodegeneration in the brain in ASD includes: (1) neuronal cell loss, (2) activated microglia and astrocytes, (3) proinflammatory cytokines, (4) oxidative stress, and (5) elevated 8-oxo-guanosine levels. The evidence from this review suggests that neurodegeneration underlies the loss of neurological function in children with ASD who have experienced regression and loss of previously acquired skills and abilities, and that research into treatments to address the issue of neurodegeneration in ASD are warranted.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fifth edition) Washington, DC: American Psychiatric Association; 2013. Diagnostic criteria for autistic disorder.
-
- Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatr. 2005;6:3–8. - PubMed
-
- Centers for Disease Control: Changes in Prevalence of Parent-reported Autism Spectrum Disorder in School-aged U.S. Children: 2007 to 2011–2012. 2013. Accessed 07/07/13. http://www.cdc.gov/nchs/data/nhsr/nhsr065.pdf. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
